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1. Introduction 
Recently several groups [l-3] have reported ex- 
periments with synthetic analogues of phosphoenol- 
pyruvate (PEP). So far only the effect of these com- 
pounds on muscle pyruvate kinase has been mea- 
sured with at least partially contradictory results. 
During our studies on the regulation of gluconeo- 
genesis we were interested in PEP analogues in order 
to get more information on the different reactions 
in which PEP participates. 
The present paper describes the effects of phos- 
phoenol-a-ketobutyrate (PEB) and phosphoenol- 
a-ketovalerate (PEV) on muscle and liver pyruvate 
kinase (EC 2.7.1.40), muscle enolase (EC 4.2.1.1 l), 
liver phosphoenolpyruvate carboxykinase (EC 4.1.1. 
32) and on the tricarboxylic acid anion carrier sys- 
tem in rat liver mitochondria. 
Both analogues are strong inhibitors of all en- 
zymes tested, with characteristic differences for the 
various enzymes. Both analogues were transported 
in exchange for citrate through the inner mitochon- 
drial membrane, but again with characteristic quan- 
titative differences. PEB inhibits gluconeogenesis 
and lactate utilization in pigeon liver homogenates. 
2. Experimental 
PEB and PEV were synthetized from the corre- 
North-Holland Publishing Company - Amsterdam 
sponding a-keto acids according to Clark and Kirby 
[4]. The products were characterized by their melt- 
ing points, their phosphate content, and by IR and 
NMR spectroscopy. The preparations were com- 
pletely free of PEP. The cyclohexyl ammonium 
salts of the analogues were converted to their corre- 
sponding sodium salts by treatment with Dowex- 
WX-50 (Na’-form). 
Pyruvate kinase from rabbit muscle, enolase from 
rabbit muscle, auxillary enzymes used for the coupled 
enzyme essays, and all coenzymes and PEP were ob- 
tained from Boehringer Mannheim Corp. Liver pyru- 
vate kinase was partially purified from rat liver 
according to Schoner et al. [S] including the am- 
monium sulfate precipitation step. For test condi- 
tions for pyruvate kinase and enolase see fig. 1. For 
the preparation of phosphoenolpyruvate carboxy- 
kinase a pigeon liver homogenate was sonified and 
centrifuged at 100,000 g for 1 hr. The supernatant 
was freed from monovalent cations and bicarbonate 
on a Sephadex G-25 column. The enzyme-containing 
fractions were pooled and freeze-dried. Under the 
test conditions used (see fig. 2) pyruvate kinase ac- 
tivity did not interfere with the determination of 
phosphoenolpyruvate carboxykinase activity. All 
enzyme essays were performed at 30”. 
Anion transport was studied in rat liver mitochon- 
dria, isolated according to Myers and Slater [6]. The 
mitochondria were loaded with 1 ,5-r4C-citrate at 0” 
according to Meijer [7] and the efflux of citrate was 
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Fig. 1. (A) and (B): Dixon plots for the determination of Ki values for PEB (fig. IA) and PEV (fig. 1B) with rabbit muscle pyru- 
vate kinase. The test conditions were as follows (final concentrations given): Triethanolamine (pH 7.6) 80 mM; ADP 1.33 mM; 
NADH 0.27 mM; MgSO, 16 mM; KC1 66.0 mM; lactate dehydrogenase (pig heart) 13.2 pg/ml; pyruvate kinase (rabbit muscle) 
0.07 pg/ml. The concentrations of PEP, PEB and PEV were varied as indicated in the graphs. (C) and (D): Dixon plots for the 
determination of Ki values for PEB (fig. 1C) and PEV (fig. 1D) with rabbit muscle enolase. The test conditions were as follows 
(final concentrations given): Triethanolamine (pH 7.6) 66 mM; ADP 1.1 mM; NADH 0.20 mM; 2,3-diphosphoglycerate 0.12 mM, 
EDTA 0.45 mM; MgS04 8.4 mM; glyceraldehyde-3-phosphate dehydrogenase (yeast) 83 rg/ml; phosphoglycerate kinase (yeast) 
16.7 I,rg/ml; phosphoglycerate mutase (rabbit muscle) 8.33 Fg/ml; enolase (rabbit muscle) 0.67 pg/ml. The concentrations of 
PEP, PEB and PEV were varied as indicated in the graphs. 
was measured at 25” in the presence of rotenone 
(2 /.&ml) using PEP [8] or the PEP analogues as 
counter anions (for details see table 1). The inhi- 
bitor benzene-l ,2,3-tricarboxylate [8] was ob- 
tained from Schuchardt and Co., Munich, Germany. 
3. Results 
3.1. Pyruvate kinase from rabbit muscle 
PEB as well as PEV are both converted to the 
corresponding cu-keto acids as can be seen from the 
fact that the reaction products led to an oxidation 
of NADH in the presence of pig heart lactate de- 
hydrogenase. At saturating concentrations (10 mM) 
PEP was 900 times more rapidly converted to the 
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Fig. 2. (A) and (B): Comparison of the homotropic cooperativity with PEP (fig. 2A) and PEB (fii. 2B) as substrates in the pyru- 
vate kinase reaction (pyruvate kinase from rat liver), and the effect of 7 PM fructose-1,6-diphosphate (FDP). For test conditions 
see legend to fig. 1. The activity of partially purified liver pyruvate kinase was about 20 munits/ml with PEP as substrate and 
about 120 munits/ml with PEB as substrate. The concentrations of PEP and PEB were varied as indicated on the abscissa. (C) and 
(D): Dixon plots for the determination of Ki values for PEB (fig. 2C) and PEV (fig. 2D) with pigeon liver phosphoenolpyruvate 
carboxykinase. The test conditions were as follows (final concentrations given): Tris-HCI (pH 7.4) 57 mM; IDP 1.17 mM; NaHCOa 
20 mM; NADH 0.63 mM; MnCla 1.17 mM; malate dehydrogenase (pig heart, free of NH: ions) 38 &ml; phosphoenolpyruvate 
carboxykinase equivalent to 25 munits/ml. The concentrations of PEP, PEB and PEV were varied as indicated in the graphs. 
corresponding a-keto acid than PEB, and 850 times 
more rapidly than PEV. It had been excluded before 
that the lactate dehydrogenase reaction was rate 
limiting. Both analogues inhibited competitively the 
conversion of PEP to pyruvate (fig. lA, B), PEB 
being about 100 times more inhibitory than PEV. 
3.2. Pyruvate kinase from rat liver 
In contrast to muscle pyruvate kinase, the L-type 
liver pyruvate kinase exhibits a strong cooperativity 
with its substrate PEP [5,9-l 11. In the presence 
of fructose-1,6-diphosphate (FDP),,however, a 
Michaelis-Menten type kinetics can be obtained 
[9-II]. 
When PEB instead of PEP was used as a substrate 
for liver pyruvate kinase, again a sigmoidal shaped 
concentration-velocity curve was obtained which 
could also be converted to a hyperbolicly shaped 
curve in the presence of FDP (fig. 2C and D). 
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Table I 3.3. Enolase from rabbit muscle 
Conditions Exchange of intramito- 
chondrial citrate (Percent 
of internal citrate ex- 
changed) 
Control 0 
PEP 73.9 
PEB 41.4 
PEV 27.4 
PEP + PEB 72.4 
PEP + PEV 74.0 
PEB + BTC 2.9 
PEB + BTC - 6.4 
PEV + BTC - 2.4 
PEP + PEB + BTC f 0 
PEP + PEV + BTC + 0.2 
Exchange of intramitochondrial 1,5-t4C-citrate with extra- 
mitochondrial PEP or PEP analogues in absence and presence 
of 50 mM benzene 1,2,3-tricarboxylate (BTC). The concen- 
tration of PEP or PEP analogues was always 1 mM in the 
single as well as in the combined experiments. 14C-citrate 
loaded mitochondria (equivalent to 5 to 6 mg mitochondrial 
protein) were incubated in the presence of PEP or PEP 
analogues, 2 pg/ml of rotenone, 0.5 pg/ml antimycin, and 
5 mM n-butylmalonate at 25” for 1 min. The mitochondria 
were rapidly separated by centrifugation and the radioacti- 
vity measured in the supernatant and the rinsed pellet. The 
results are corrected for time dependent spontaneous leak- 
age of citrate. The percentage of exchange was calculated 
according to Robinson and Williams [ 13 j For further de- 
tails see (121. 
Table 2 
Inhibition by PEB (1 mM) of glucose formation and L-lactate 
utilization with pigeon liver homogenate. 
Net formation Net utilization 
of glucose of L-lactate 
(pmoles/g wet liver/60 min) 
Controls 64.15 + 2.04 376.39 + 12.93 
With 1 mM PEB 33.60 * 1.11 212.68 f 8.27 
p-value < 0.001 < 0.001 
The pigeon liver homogenate and the incubation medium 
were prepared according to Krebs et al. [ 151. The homo- 
genates were incubated at 40” for 60 min. The reaction 
was stopped by addition of HC104. Values given are mean 
values t S.E.M. 
Both PEP-analogues are strong competitive in- 
hibitors of enolase, PEB again being about 100 
times more inhibitory than PEV (fig. 1 C and D). 
The Kj values for both analogues are in the same 
range as for muscle pyruvate kinase. It had been 
excluded by control experiments that the PEP- 
analogues might inhibit one of the auxillary en- 
zymes. 
3.4. Phosphoenolpyruvate carboxykinase from 
pigeon liver 
Both PEP-analogues are very strong competitive 
inhibitors of this enzyme (fig. 2C and D). In con- 
trast to pyruvate kinase and enolase, phosphoenol- 
pyruvate carboxykinase was nearly as strongly in- 
hibited by PEV as by PEB. It was excluded that 
the PEP analogues might inhibit malate dehydro- 
genase. 
3.5. Exchange with citrate through the inner mito- 
chondrial membrane 
As can be seen from table 1, both analogues ex- 
change with mitochondrial citrate. PEB exchanges 
slightly, PEV considerably less in comparison to 
PEP. Neither PEB nor PEV inhibit the exchange of 
PEP with citrate. Similarly to the PEP/citrate ex- 
change, the PEB/citrate exchange as well as the PEV/ 
citrate exchange are strongly inhibited by benzene- 
1,2,3_tricarboxylate (table 1). 
4. Discussion 
In accordance with recent reports of Bondinell 
and Sprinson [ 11, and Stubbe and Kenyon [3], 
but in contrast to Woods et al. [2], PEB and PEV 
were shown to be not only inhibitors but also sub- 
strates for the pyruvate kinase reaction. 
The Kj value with muscle pyruvate kinase for 
PEB corresponds to the value measured by Woods 
et al. [2], who found a value of 6.5 X lo-’ M. 
Our Kj value for PEV, however, is higher than their 
value of 1.07 X low4 M. The fact that with pyruvate 
kinase and enolase the Ki values for PEB were about 
100 times lower than for PEV, but that no great 
difference could be found with phosphoenolpyruvate 
carboxykinase, points to a large difference in the prop 
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erties of the PEP binding site in the latter enzyme as References 
December 1971 
compared with pyruvate kinase and enolase. 
The difference between PEB and PEV became 
again visible when the mitochondrial PEP analogue/ 
citrate exchange was measured. 
From the results reported one could expect an 
inhibition of gluconeogenesis by PEP analogues. 
When the net formation of glucose from 10 mM L- 
lactate by a pigeon liver homogenate was measured 
according. to Krebs et al. [ 151, we found indeed a 
significant inhibition of glucose formation and lac- 
tate utilization (table 2). 
Further experiments with more lipophilic PEP- 
analogues are under way. Moreover, the question 
has to be answered whether PEB and/or PEV are 
converted by enolase or phosphoenolpyruvate car- 
boxykinase to the corresponding reaction products. 
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